Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irving Kirsch

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Handbook of Experimental Pharmacology|October 12, 2014
The emperor's new drugs: medication and placebo in the treatment of depressionIrving Kirsch
Contemporary Clinical Trials|May 17, 2015
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differencesJoanna Moncrieff, Irving Kirsch
BMJ (Clinical Research Ed.)|July 16, 2005
Efficacy of antidepressants in adultsJoanna Moncrieff, Irving Kirsch
Contemporary Clinical Trials|December 22, 2006
Clinical trials and the response rate illusionIrving Kirsch, Joanna Moncrieff
The International Journal of Clinical and Experimental Hypnosis|August 1, 2022
The Proposed Task Force Hypnosis Efficacy Guidelines: The Role of Moderation and Mediation in Efficacy TrialsGuy H Montgomery, Irving Kirsch
Lancet (London, England)|September 29, 2018
Network meta-analysis of antidepressantsIrving Kirsch, Janus Christian Jakobsen
The American Journal of Clinical Hypnosis|March 16, 2013
Suggestion in the treatment of depressionIrving Kirsch, Carol B Low
Annual Review of Clinical Psychology|December 17, 2013
Drug approval and drug effectivenessGlen I Spielmans, Irving Kirsch
BMJ (Clinical Research Ed.)|March 22, 2008
Moving beyond depression: How full is the glass?Irving Kirsch, Blair T Johnson
The American Journal of Clinical Hypnosis|June 20, 2024
Re-thinking the treatment of depression: have we been misinformed about antidepressants? A webinar discussion with Irving Kirsch, Ph.D. and Michael D. Yapko, Ph.DIrving Kirsch, Michael D Yapko
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Handbook of Experimental Pharmacology|October 12, 2014
The emperor's new drugs: medication and placebo in the treatment of depressionIrving Kirsch
Contemporary Clinical Trials|May 17, 2015
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differencesJoanna Moncrieff, Irving Kirsch
BMJ (Clinical Research Ed.)|July 16, 2005
Efficacy of antidepressants in adultsJoanna Moncrieff, Irving Kirsch
Contemporary Clinical Trials|December 22, 2006
Clinical trials and the response rate illusionIrving Kirsch, Joanna Moncrieff
The International Journal of Clinical and Experimental Hypnosis|August 1, 2022
The Proposed Task Force Hypnosis Efficacy Guidelines: The Role of Moderation and Mediation in Efficacy TrialsGuy H Montgomery, Irving Kirsch
Lancet (London, England)|September 29, 2018
Network meta-analysis of antidepressantsIrving Kirsch, Janus Christian Jakobsen
The American Journal of Clinical Hypnosis|March 16, 2013
Suggestion in the treatment of depressionIrving Kirsch, Carol B Low
Annual Review of Clinical Psychology|December 17, 2013
Drug approval and drug effectivenessGlen I Spielmans, Irving Kirsch
BMJ (Clinical Research Ed.)|March 22, 2008
Moving beyond depression: How full is the glass?Irving Kirsch, Blair T Johnson
The American Journal of Clinical Hypnosis|June 20, 2024
Re-thinking the treatment of depression: have we been misinformed about antidepressants? A webinar discussion with Irving Kirsch, Ph.D. and Michael D. Yapko, Ph.DIrving Kirsch, Michael D Yapko
Pageof 15